Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer

Clinical trial NCT00306137 · TERMINATED

Trial details

NCT number: NCT00306137
Sponsor: Bayer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Blood Loss, Surgical

Start date: 2005-12-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.